M, Z., S, L., J, D., C, H., & H, Z. (2025). Identification and Clinical Validation of High HSP60 Expression Predicts Poor Prognosis in Patients with Ovarian Cancer. International Journal of General Medicine, ume 18, 103-111.
Chicago-referens (17:e uppl.)M, Zheng, Li S, Deng J, Huang C, och Zhang H. "Identification and Clinical Validation of High HSP60 Expression Predicts Poor Prognosis in Patients with Ovarian Cancer." International Journal of General Medicine ume 18 (2025): 103-111.
MLA-referens (9:e uppl.)M, Zheng, et al. "Identification and Clinical Validation of High HSP60 Expression Predicts Poor Prognosis in Patients with Ovarian Cancer." International Journal of General Medicine, vol. ume 18, 2025, pp. 103-111.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.
